You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1 gene Mutation

Showing 1 - 25 of 9,425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

Recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • Informational Intervention
  • Survey Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Breast & Ovarian Cancer Risk Detection

Recruiting
  • Adnexal Mass
  • +3 more
  • OVA360
  • Austin, Texas
    Silvana Franco
Jul 20, 2022

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Prospective Research of Outcomes After Salpingo-oophorectomy

Active, not recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +2 more
    • Salpingectomy with delayed oophorectomy
    • Risk-reducing salpingo-oophorectomy
    • Maastricht, Limburg, Netherlands
    • +12 more
    May 17, 2022

    BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

    Recruiting
    • BARD1 Gene Mutation
    • +14 more
    • Educational Intervention
    • +3 more
    • Houston, Texas
    • +1 more
    Jun 14, 2022

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

    Active, not recruiting
    • Deleterious BRCA1 Gene Mutation
    • +5 more
    • Behavioral, Psychological or Informational Intervention
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed

    Recruiting
    • BRCA1 Gene Mutation
    • +5 more
    • Risk-reducing salpingectomy with delayed oophorectomy
    • Risk-reducing salpingo-oophorectomy
    • Tilburg, Brabant, Netherlands
    • +13 more
    Nov 1, 2022

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • (no location specified)
    Aug 10, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

    Recruiting
    • BRCA1 Gene Mutation
    • +19 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • New Brunswick, New Jersey
    • +1 more
    Nov 16, 2022

    Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

    Active, not recruiting
    • Deleterious BARD1 Gene Mutation
    • +13 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Chicago, Illinois
    • +8 more
    Feb 25, 2022

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +9 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 16, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

    Recruiting
    • Advanced Breast Carcinoma
    • +14 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 31, 2022

    Impact of Positive BRCA1/2 Mutation Status on Lives of Young

    Completed
    • BRCA1 Gene
    • BRCA2 Gene
      • Bethesda, Maryland
        National Cancer Institute (NCI), 9000 Rockville Pike
      Nov 26, 2021

      An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

      Recruiting
      • Prostate Cancer
      • +2 more
      • MRI pelvis or CT imaging
      • +2 more
      • London, Sutton, Surrey, United Kingdom
        Cancer Genetics Unit, Royal Marsden Hospital
      Mar 30, 2022